Cardiac Science Losses
- Share via
Cardiac Science Inc., Irvine maker of medical devices, lost $1.1 million, or 22 cents a share, for the second quarter, compared with a net loss of $271,078, or 8 cents a share, for the 1997 second quarter. The company said expenses related to the development of the commercial version of its defibrillator-monitor totaled $577,452. Revenue declined 13% to $355,644 from $408,998.
For the six-month period, the company posted a net loss of $1.8 million, or 36 cents a share, compared with a net loss of $439,553, or 13 cents a share, for the first half of 1997. Revenue rose 96% to $802,356 from $408,998.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.